Monitoring side effects of COVID-19 vaccines worldwide
COVID-19 Vaccines Safety Tracking: Global Consortium Study
This study is tracking the side effects of COVID-19 vaccines in healthcare workers, older adults, and schoolteachers to see how common they are and if certain factors affect them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Masaryk University Academic / other |
| Locations | 14 sites (Philadelphia, Pennsylvania and 13 other locations) |
| Trial ID | NCT04834869 on ClinicalTrials.gov |
What this trial studies
This project actively tracks the side effects of COVID-19 vaccines among healthcare workers, older adults, and schoolteachers. It aims to estimate the prevalence of local and systemic side effects, evaluate demographic and medical risk factors, and assess long-term consequences of vaccination. Additionally, the study compares the safety of different COVID-19 vaccines and examines the impact of palliative medications on short-term side effects. The findings will contribute to public health efforts to improve vaccine uptake and address vaccine hesitancy.
Who should consider this trial
Good fit: Ideal candidates include healthcare workers, older adults over 65, and schoolteachers who have received a COVID-19 vaccine.
Not a fit: Patients who are not healthcare workers, older adults, or schoolteachers and have not received a COVID-19 vaccine will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of vaccine safety and improve public confidence in COVID-19 vaccination.
How similar studies have performed: Other studies have successfully monitored vaccine safety, making this approach both relevant and necessary in the current context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * HCW, OA and ST who received COVID-19 vaccine. * Participating subjects should be at least 18-year-old and able to give their informed consent independently. Exclusion Criteria: * Non HCW, OA and ST who received the COVID-19.
Where this trial is running
Philadelphia, Pennsylvania and 13 other locations
- American College of Physicians — Philadelphia, Pennsylvania, United States (Not_yet_recruiting)
- McMaster University — Hamilton, Ontario, Canada (Not_yet_recruiting)
- University of Split — Split, Croatia (Not_yet_recruiting)
- Masaryk University — Brno, Czechia (Recruiting)
- University of Tartu — Tartu, Estonia (Not_yet_recruiting)
- Jimma University — Jimma, Ethiopia (Recruiting)
- Justus-Liebig University Giessen — Giessen, Germany (Recruiting)
- University of Ghana — Accra, Ghana (Not_yet_recruiting)
- Sinaloa's Pediatric Hospital — Culiacán, Mexico (Not_yet_recruiting)
- Medical University of Silesia — Katowice, Poland (Recruiting)
- Nursing School of Coimbra — Coimbra, Portugal (Not_yet_recruiting)
- Irkutsk Scientific Center of Siberian Branch of Russian Academy of Sciences — Irkutsk, Russia (Recruiting)
- University of Belgrade — Belgrade, Serbia (Recruiting)
- University of Ljubljana — Ljubljana, Slovenia (Not_yet_recruiting)
Study contacts
- Study coordinator: Miloslav Klugar, PhD
- Email: klugar@med.muni.cz
- Phone: +420549495676
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.